Synovial Sarcoma Around the Heart: Rare Case Highlights Importance of Early Diagnosis

Synovial sarcoma is a rare soft tissue cancer that usually develops near joints in the arms or legs. However, in very rare cases, it can appear in unexpected places — including the pericardium, the lining around the heart.

A recent case report describes a 23-year-old patient diagnosed with primary pericardial synovial sarcoma, an extremely uncommon and aggressive form of the disease.

A Rare and Complex Case

The patient initially experienced symptoms such as:

• Persistent cough
• Fever
• Weight loss

Imaging tests revealed a large mass near the heart, along with fluid buildup around the heart (pericardial effusion).

Because these symptoms are not specific, diagnosis can be delayed — especially when synovial sarcoma appears outside its usual locations.

How the Diagnosis Was Made

Doctors used a combination of:

• CT scans and imaging
• Surgical removal of the tumor
• Immunohistochemistry (IHC) testing

The tumor tested positive for markers such as BCL-2, TLE1, and CD99, which are commonly seen in synovial sarcoma.

These tests helped confirm the diagnosis of monophasic synovial sarcoma, a subtype made up mainly of spindle-shaped tumor cells.

Why Synovial Sarcoma Can Be Hard to Diagnose

Synovial sarcoma is often difficult to diagnose because:

• It can appear in unusual locations like the heart or lungs
• Symptoms are often vague and nonspecific
• It can look similar to other types of tumors

A key feature of synovial sarcoma is a genetic change called the SS18-SSX gene fusion, found in most cases and used to confirm the diagnosis.

Treatment and Challenges

Treatment for synovial sarcoma in the heart is complex and may include:

• Surgery to remove the tumor
• Chemotherapy (commonly doxorubicin and ifosfamide)
• Radiation therapy

Because of the tumor’s location near critical structures, complete removal can be difficult, and overall prognosis remains challenging.

What This Means for the Synovial Sarcoma Community

This case reinforces several key realities of synovial sarcoma:

• It can occur in rare and unexpected locations, including the heart
• Symptoms may be nonspecific, leading to delayed diagnosis
• Early detection and expert care are critical
• Treatment can be more complex depending on tumor location

The Role of Biomarker Testing

Biomarker testing plays a key role in confirming synovial sarcoma and guiding treatment options.

Patients and caregivers should consider asking their care team about:

• HLA typing
• MAGE-A4 testing
• NY-ESO-1 testing

These tests may help determine eligibility for:

• Targeted therapies
• Cell therapies such as Tecelra
• Clinical trials and emerging treatments

If these tests have not been completed, they can be requested. Labs such as Caris Life Sciences and Tempus specialize in sarcoma molecular profiling.

Biomarker testing is an important step in understanding your full range of treatment options.

For more resources, visit: www.sarcomabiomarkertesting.com

For more detailed information, please refer to the original publication. For more information about synovial sarcoma resources and support, please visit our website.